论文部分内容阅读
Targeted delivery of therapeutic nanoparticles have shown a significant feature in disease-specific manner compared with non-target nanoparticles.We have developed NPs formulated with poly(D,L-lactic-co-glycolic acid)-block-poly(ethylene-glycol)(PLGA-b-PEG)copolymer and decorated with an aptamer.The aptamer SYL3C can bind itself to the surface protein of circulating tumor cells(CTCs),epithelial cell adhesion molecule(EPCAM),which is overexpressed targeting ligand to promote the anti-tumor-metastasis delivery of Ursolic acid(UA).